BIOMAT Database Logo BIOMAT Database Logo

[The HLA system and diffuse toxic goiter]. 1990

T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013971 Thyrotoxicosis A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING. Thyrotoxicoses

Related Publications

T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina
[The HLA system in diffuse toxic goiter].
January 1990, Problemy endokrinologii,
T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina
[HLA antigens in diffuse toxic goiter].
January 1991, Problemy endokrinologii,
T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina
HLA antigens and diffuse toxic goiter in Taiwan.
January 1978, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina
[HLA haplotypes and the predisposition to diffuse toxic goiter].
January 1994, Terapevticheskii arkhiv,
T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina
[Diffuse toxic goiter].
September 1984, Fel'dsher i akusherka,
T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina
[Diffuse toxic goiter].
January 1984, Meditsinskaia sestra,
T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina
[Diffuse toxic goiter].
February 1973, Meditsinskaia sestra,
T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina
[Diffuse toxic goiter].
January 1992, Fel'dsher i akusherka,
T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina
[Diffuse toxic goiter].
January 1992, Klinicheskaia meditsina,
T S Kamynina, and A P Kalinin, and S I Donskov, and E G Klimova, and T V Ivanenko, and A R Zlatkina
HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
April 1983, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!